Report Feature
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global protein binding assay market report, please download the report brochure.
- Instrument
- Kits & Reagents
- Services
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- Equilibrium Dialysis
- Ultrafiltration
- Ultracentrifugation
- Other Technologies
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Pharmaceutical & Biotechnology Companies
- Contract Research Organization
- Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the protein binding assays companies profiled in this report include Merck, Thermo Fisher Scientific, GE Healthcare, Sovicell, Absorption Systems, HTdialysis, Eurofins Scientific, ADMEcell, 3B Pharmaceuticals, Biotium, and Danaher.
Lucintel forecasts that instruments will remain the fastest growing product and service segment over the forecast period due to rising demand for user-friendly instruments and automated systems for detection of protein binding.
Within this market, pharmaceutical and biotechnology companies will remain the largest segment by end user over the forecast period due to increasing protein binding studies for drug discovery & development and the rising focus on development of biologics.
North America will remain the largest region over the forecast period due to increasing research activities related to drug discovery and presence of major pharmaceutical and biotechnology companies in the region.
|
Features of the Global Protein Binding Assay Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global protein binding assay market by product & service (instrument, kits & reagents, and services), technology (equilibrium dialysis, ultrafiltration, ultracentrifugation, and other technologies), end user (pharmaceutical & biotechnology companies, contract research organization, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global protein binding assay market? Q.5 What are the business risks and threats to the global protein binding assay market? Q.6 What are the emerging trends in this protein binding assay market and the reasons behind them? Q.7 What are some changing demands of customers in this protein binding assay market? Q.8 What are the new developments in this protein binding assay market? Which companies are leading these developments? Q.9 Who are the major players in this protein binding assay market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this protein binding assay market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global protein binding assay market? |
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product & Services (Instrument, Kits & Reagents, and Services), Technology (Equilibrium Dialysis, Ultrafiltration, Ultracentrifugation, and Other Technologies), and End User (Pharmaceutical & Biotechnology Companies, Contract Research Organization, and Others) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
Methodology
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.